The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats

To investigate whether oestrogen, selective oestrogen receptor modulators (SERMs), and growth hormone (GH) can prevent the development of voiding dysfunction in a postpartum postmenopausal rat model of voiding dysfunction.

[1]  M. Damaser,et al.  Increased duration of simulated childbirth injuries results in increased time to recovery. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[2]  S. Juma,et al.  Transobturator tape (TOT): Two years follow‐up , 2007, Neurourology and urodynamics.

[3]  Phillip P Smith,et al.  Current trends in the evaluation and management of female urinary incontinence , 2006, Canadian Medical Association Journal.

[4]  S. K. Van Den Eeden,et al.  Quality-of-life impact and treatment of urinary incontinence in ethnically diverse older women. , 2006, Archives of internal medicine.

[5]  C. Chapple,et al.  Developments in pharmacological therapy for the overactive bladder , 2006, BJU international.

[6]  T. Streng,et al.  Phasic non‐micturition contractions in the bladder of the anaesthetized and awake rat , 2006, BJU international.

[7]  D. Cox,et al.  Extracellular matrix integrity: A possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens? , 2006, Molecular and Cellular Endocrinology.

[8]  E. Vittinghoff,et al.  The Effect of Ultralow-Dose Transdermal Estradiol on Urinary Incontinence in Postmenopausal Women , 2005, Obstetrics and gynecology.

[9]  E. Vittinghoff,et al.  Postmenopausal Hormone Therapy: Does It Cause Incontinence? , 2005, Obstetrics and gynecology.

[10]  P. Albertazzi,et al.  Urogenital effects of selective estrogen receptor modulators: a systematic review , 2005, Climacteric : the journal of the International Menopause Society.

[11]  N. Watts,et al.  Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen , 2005, Menopause.

[12]  R. Wallace,et al.  Effects of estrogen with and without progestin on urinary incontinence. , 2005, The Journal of urology.

[13]  S. Steel,et al.  Effect of pure genistein on bone markers and hot flushes , 2005, Climacteric : the journal of the International Menopause Society.

[14]  S. Cummings,et al.  Effect of Raloxifene on Urinary Incontinence: A Randomized Controlled Trial , 2004, Obstetrics and gynecology.

[15]  M. Damaser,et al.  Functional and neuroanatomical effects of vaginal distention and pudendal nerve crush in the female rat. , 2003, The Journal of urology.

[16]  R. Lindsay,et al.  Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. , 2003, American journal of obstetrics and gynecology.

[17]  J. Kerns,et al.  Effects of IGF-I gene therapy on the injured rat pudendal nerve , 2003, International Urogynecology Journal.

[18]  S. Goldstein,et al.  Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. , 2002, American journal of obstetrics and gynecology.

[19]  T. Lue,et al.  Long-term effect of ovariectomy and simulated birth trauma on the lower urinary tract of female rats. , 2002, The Journal of urology.

[20]  T. Lue,et al.  The effect of simulated birth trauma and/or ovariectomy on rodent continence mechanism. Part I: functional and structural change. , 2001, The Journal of urology.

[21]  F. Cheater,et al.  Epidemiology and classification of urinary incontinence. , 2000, Bailliere's best practice & research. Clinical obstetrics & gynaecology.

[22]  K. Andersson,et al.  Drug therapy for urinary incontinence. , 2000, Bailliere's best practice & research. Clinical obstetrics & gynaecology.

[23]  Finkbeiner,et al.  The pharmacological treatment of urinary incontinence , 1999, BJU international.

[24]  T. Lue,et al.  IGF-I and TGF-β2 have a key role on regeneration of nitric oxide synthase (NOS)-containing nerves after cavernous neurotomy in rats , 1999, International Journal of Impotence Research.

[25]  A. Herzog,et al.  Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. , 1999, Obstetrics and gynecology.

[26]  T. Lue,et al.  Effect of simulated birth trauma on the urinary continence mechanism in the rat. , 1998, Urology.

[27]  A. Oldfors,et al.  Skeletal muscle regeneration in young rats is dependent on growth hormone , 1991, Journal of the Neurological Sciences.

[28]  M. Swash,et al.  Effect of vaginal delivery on the pelvic floor: A 5‐year follow‐up , 1990, The British journal of surgery.

[29]  K. Jensen,et al.  [Urinary incontinence in women]. , 1984, Ugeskrift for laeger.

[30]  A. Herzog,et al.  Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. , 1999, Obstetrics and gynecology.

[31]  J. Lessing,et al.  Stress urinary incontinence: Prevalence among nulliparous compared with primiparous and grand multiparous premenopausal women , 1999, Neurourology and urodynamics.